All Categories
Refine Search
TD139 (33DFTG)
Novel galectin-3 inhibitor, reducing both pathological corneal neovascularization and fibrosis
Tecalcet Hydrochloride (R-568)
Type II calcimimetic agent, acting on parathyroid cell calcium receptor
Novel galectin-3 inhibitor, reducing both pathological corneal neovascularization and fibrosis
Type II calcimimetic agent, acting on parathyroid cell calcium receptor